Kaleido

Utrecht, Netherlands · Founded 2013 · Privately Held (backing)

Developer of medical devices designed to be used for the treatment of diabetes. Kaleido is based in Utrecht, Netherlands and was founded in 2013. It has raised $194 million.

Last price · $/share
—
Implied valuation
—
Total raised
$193.6M
Last round
—

Who backs Kaleido?

10 investors
InvestorType
Invest-NL (Investment Company)Other
EQT Life SciencesVenture capital
ROM Utrecht RegionOther
EQTPE / buyout
Partners in EquityOther
Health Innovations—
Inkef—
Innovation Industries (Amsterdam)—
Kreos Capital—
Venturing (Netherlands)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kaleido investors

10 investors are on record for Kaleido, including Invest-NL (Investment Company), EQT Life Sciences, ROM Utrecht Region and EQT.

Free account
More of Kaleido with a free account
  • ·Watch Kaleido: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Kaleido. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View